Inflammation markers and antioxidant activity in patients with bronchiectasis Source: Eur Respir J 2001; 18: Suppl. 33, 217s Year: 2001
Parameters of antioxidant protection in patients with cryptogenic fibrosing alveolitis Source: Annual Congress 2007 - Considerations in the therapeutic approach of interstitial lung disease: oxidative stress and inflammation Year: 2007
The effects of antioxidant therapy on lung clearance, pulmonary function test and oxidant stress in patients with COPD Source: Eur Respir J 2002; 20: Suppl. 38, 258s Year: 2002
Role of antioxidant in patients with COPD Source: Eur Respir J 2001; 18: Suppl. 33, 249s Year: 2001
Lipid peroxidation and antioxidative enzymes in patients with COPD: relationship to pulmonary hyperinflation Source: Eur Respir J 2006; 28: Suppl. 50, 35s Year: 2006
Role of systemic and bronchial oxidative stress and inflammation in lung cancer predisposition in patients with COPD Source: Annual Congress 2011 - Biomarkers and other new methods for lung cancer Year: 2011
Some aspects of antioxidant protection in patients with tuberculosis after lung parenchyma sparing resection Source: International Congress 2016 – Open problems in thoracic surgery Year: 2016
Comparison of the neutrophils oxidative activity in patients with occupational lung diseases and COPD Source: Eur Respir J 2003; 22: Suppl. 45, 119s Year: 2003
Lung function and haematological changes in patients with sarcoidosis Source: Eur Respir J 2007; 30: Suppl. 51, 116s Year: 2007
Lung function at patients with sarcoidosis Source: Eur Respir J 2002; 20: Suppl. 38, 432s Year: 2002
Neutrophils oxidative activity of patients with occupational lung diseases Source: Eur Respir J 2001; 18: Suppl. 33, 445s Year: 2001
Impaired oxidant/antioxidant balance and relationships between inflammatory markers and antioxidants in patients with primary lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 86s Year: 2006
Antioxidant and inflammatory status in lung cancer patients: systemic or local correlation? Source: Eur Respir J 2006; 28: Suppl. 50, 769s Year: 2006
Reduced anti-oxidant and increased inflammatory status in interstitial lung diseases (ILD) Source: Eur Respir J 2007; 30: Suppl. 51, 110s Year: 2007
ACE and sIL2-R predict lung function improvement in sarcoidosis during methotrexate therapy Source: Annual Congress 2013 –Sarcoidosis Year: 2013
Assessment of innate immunity mediators in the lung of COPD patients: relation with disease manifestations Source: Virtual Congress 2020 – Host-microbe interactions and their influence on lung disease onset and severity Year: 2020
Assessment of lipid peroxidation and antioxidant capacity in pulmonary parenchyma and lung cancer tissue in non-small cell lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 79s Year: 2004
Effects of antioxidant supplementation on ozone-induced lung injury in healthy human subjects Source: Eur Respir J 2001; 18: Suppl. 33, 411s Year: 2001
Induction of antioxidant defense mechanisms by amifostine in lung tissue attenuates ventilator induced lung injury Source: Annual Congress 2010 - New insights into reactive oxygen species Year: 2010
Lung diffusing capacity and the relevant parameters in patients with autoimmune diseases Source: Annual Congress 2009 - Impact on respiratory function of pulmonary and extrapulmonary diseases Year: 2009